Summary: UCLQ coordinates ~120 researchers across a rich range of quantum sensing disciplines. The AMOPP group spans levitated optomechanics (Barker), atomic magnetometry and MIT imaging (Renzoni), femtosecond biosensing (Bain), quantum biology theory (Olaya-Castro), Rydberg atoms (Hogan), and molecular precision physics (Caldwell). The Biological Physics group (Llorente-Garcia) addresses quantum effects in biological systems. UCL is particularly notable for quantum sensing applied to biology, including radical-pair mechanisms, optical magnetometry for MEG, and super-resolution biosensing. The London Centre for Nanotechnology (LCN) provides shared fabrication facilities.
Notes: Top-10 UK research university (QS #9 global). The UCLQ Quantum Science and Technology Institute coordinates ~120 researchers. Key groups in scope: AMOPP group โ levitated optomechanics (Barker), atomic magnetometry / MIT imaging (Renzoni), femtosecond biosensing (Bain), quantum biology theory (Olaya-Castro), Rydberg atoms (Hogan), molecular precision physics (Caldwell), quantum optomechanics theory (Monteiro). Biological Physics group (Llorente-Garcia). Member of UK National Quantum Technologies Programme. London Centre for Nanotechnology shares facilities.
Jones's group develops optical tweezers instrumentation for biological applications. Research directions: (1) Single-cell mechanics โ using optical traps to apply calibrated forces to cells and measure viscoelastic properties relevant to cancer invasion and immune response; (2) Motor protein biophysics โ measuring force-velocity curves of kinesin/myosin motors at the single-molecule level; (3) Optical sorting โ holographic optical tweezers for cell sorting by mechanical phenotype; (4) Instrument development โ fast-switching AOD-based traps, quantitative phase imaging combined with force measurement. Sensitive to pN forces, combining biosensing with fundamental biophysics.
McKendry co-directs Q-BIOMED, the UK's national quantum-biomedical-sensing research hub (UKRI/NIHR, ~GBP24M), which brings NV-diamond and other quantum sensors into clinical diagnostics. Her own group has developed nitrogen-vacancy nanodiamond-labelled lateral-flow and rapid molecular tests -- including a quantum-enhanced SARS-CoV-2 antigen test and single-molecule HIV RNA detection -- that exploit resonant microwave control of the NV spin state to separate signal from background and push rapid point-of-care diagnostics toward single-molecule sensitivity, a direct human-diagnostics application of quantum sensing.
Miller develops nitrogen-vacancy nanodiamond quantum biosensors for rapid diagnostics, controlling the NV spin state with resonant green/microwave illumination to frequency-separate fluorescence signal from background and achieve single-molecule detection of nucleic acids (e.g. HIV RNA with a short isothermal amplification step) in lateral-flow and widefield formats. His current projects span nanodiamond sensors for point-of-care disease diagnostics, quantum sensing at neural-interface implants, and wide-field quantum sensing of large randomly-oriented nanodiamond ensembles in biological samples, actively recruiting PhD students through the Q-BIOMED hub.
Monteiro works on the theory and control of levitated optomechanical systems, including a stable 3D velocity feedback cooling scheme for independently controlling all three translational modes of an optically levitated nanoparticle with minimal cross-talk. Levitated optomechanics of this kind is being developed both as a force/impulse sensor of exquisite sensitivity and, in collaboration with UCL colleagues including Peter Barker, as a testbed for macroscopic quantum states relevant to proposed gravity-entanglement experiments.
Morton directs UCL's Quantum Science and Technology Institute and is Deputy Director of the Q-BIOMED hub. His group manipulates electron and nuclear spins in nanoscale materials (silicon donors, diamond defects) to build quantum sensors, quantum memories, and quantum computing hardware, and within Q-BIOMED is pursuing magnetic-resonance quantum sensing at the single-cell level. He is also a co-founder of the quantum computing spinouts Quantum Motion and Phasecraft.
Nguyen's group at UCL (based at Royal Institution) focuses on magnetic and fluorescent nanoparticles for biomedical sensing and therapy. Research directions: (1) Magnetic nanoparticle synthesis โ iron oxide (SPION) and other magnetic nanoparticles with controlled size, shape, and surface chemistry for MRI contrast and magnetic hyperthermia; (2) Biosensing platforms โ functionalized nanoparticles as MRI-detectable sensors for specific biomolecular targets; magnetic particle imaging (MPI) for real-time tracking; (3) Plasmonic nanoparticles โ gold nanoparticles for optical biosensing and photothermal therapy; (4) Fluorescent nanoparticles โ QD- and dye-conjugated probes for live-cell imaging. Relevant to quantum sensing through magnetic nanoparticle platforms.
Olaya-Castro leads theoretical research on quantum phenomena in biological systems. Research directions: (1) Quantum coherence in photosynthesis โ open quantum systems theory for energy transfer in light-harvesting complexes, probing whether quantum coherence provides functional advantage; vibronic coupling models for chromophore-protein complexes; (2) Counting statistics and noise in exciton and charge transfer; (3) Quantum thermodynamics of biomolecular machines โ efficiency limits and entropy production in molecular motors; (4) Non-classical features of electronic/vibrational dynamics in chromophores; (5) Connections between quantum information measures and biological function. Collaborates with Bain and Llorente-Garcia on joint experiment/theory biosensing projects. Theoretical work only โ no experimental activity.
Oppenheim developed a 'postquantum theory of classical gravity' in which spacetime remains fundamentally classical while quantum theory itself is modified, predicting stochastic fluctuations in spacetime that would manifest as an unpredictable, diffusive fluctuation in the measured weight of a precisely-monitored mass. He has proposed and is pursuing precision-mass experiments to test this prediction against the alternative (Bose-Marletto-Vedral-style) entanglement-witness route to probing the quantum nature of gravity, offering a theoretically distinct but experimentally complementary approach within UCL's quantum-gravity-sensing programme.
Pankhurst directs the UCL Healthcare Biomagnetics Laboratory, developing magnetic nanoparticles and instrumentation for clinical use: AC-susceptometry-based sentinel-lymph-node localization for breast cancer surgical staging (commercialized as Endomag), magnetic particle imaging, and magnetic hyperthermia therapy. He is a participant in the Q-BIOMED quantum-biomedical-sensing hub, connecting magnetic biosensing with the hub's broader quantum-diagnostics translation effort.
Renzoni's group is internationally recognized as a pioneer in electromagnetic induction imaging (EMI) with optical atomic magnetometers. Research directions: (1) All-optical 87Rb atomic magnetometer MIT โ demonstrated first magnetic induction tomography (MIT) with atomic magnetometers (2013), first EMI of biological tissues below the 1 Smโปยน threshold (Applied Physics Letters 2020), enabling non-invasive cardiac conductivity imaging; (2) Unshielded RF atomic magnetometer operation with general regression neural network auto-optimization; (3) Non-destructive evaluation โ industrial corrosion/defect imaging via quantum-sensitive MIT; (4) Sub-Fourier signal processing with nonlinear systems for frequency resolution beyond classical limits. Collaborates with NPL on quantum sensing standards. Applications span medicine (atrial fibrillation), security, and materials inspection.